3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Brain Neoplasms
4
Radiation Injuries
1
Prostatic Neoplasms
1
Pituitary Neoplasms
1
Neuroendocrine Tumors
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, B-Cell
1
Lymphoma
1
Liver Neoplasms
1
Liver Diseases
1
Glioma
1
Fibrosis
1
Fatigue
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Hepatocellular
1
Cancer Related Cognitive Difficulties
1
Breast Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
19
Temozolomide
16
Radiotherapy
10
Specimen Handling
7
Blood Specimen Collection
7
Radiation
6
Bevacizumab
5
Nivolumab
4
Cyclophosphamide
4
Biopsy
4
vorasidenib
3
trametinib
3
pembrolizumab
3
olaparib
3
fludarabine
3
dabrafenib
3
Watchful Waiting
3
Surgical Procedures, Operative
3
Magnetic Resonance Imaging
3
Drug Therapy
3
olutasidenib
2
lutetium Lu 177 dotatate
2
fluorodopa F 18
2
fluciclovine F-18
2
entrectinib
2
contrast agent BR1
2
Restraint, Physical
2
Radiosurgery
2
Microdialysis
2
Flucytosine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Glioma
×
Neuropsychological Tests
×
Clear all
NCT05727605
2024-05-08
NARCiS
Universitaire Ziekenhuizen KU Leuven
Phase NA
Recruiting
120 enrolled